Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.49465
+0.01615 (3.38%)
At close: Aug 25, 2026
RVPH Market Cap
RVPH has a market cap or net worth of $6.49 million as of August 26, 2026. Its market cap has decreased by -82.29% in one year.
Market Cap
6.49M
Enterprise Value
-13.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.49
ChartMarket Cap Chart
Since October 18, 2018, RVPH's market cap has decreased from 25.21M to 6.49M, a decrease of -74.28%. That is a compound annual growth rate of -15.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 6.49M | -80.11% |
| Dec 31, 2025 | 32.60M | -61.33% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 10.81M |
| Zenith Capital | 7.99M |
| Adaptimmune Therapeutics | 7.16M |
| Curative Biotechnology | 7.15M |
| Hepion Pharmaceuticals | 6.77M |
| TRON Group | 5.70M |
| Institute of Biomedical Research | 4.95M |
| LianMedical | 4.30M |